142 related articles for article (PubMed ID: 26473290)
1. Insights into the role of immunosenescence during varicella zoster virus infection (shingles) in the aging cell model.
Kim JA; Park SK; Kumar M; Lee CH; Shin OS
Oncotarget; 2015 Nov; 6(34):35324-43. PubMed ID: 26473290
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
Choi EJ; Lee CH; Shin OS
Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
[TBL] [Abstract][Full Text] [Related]
3. Age-Associated Differences in Infection of Human Skin in the SCID Mouse Model of Varicella-Zoster Virus Pathogenesis.
Zerboni L; Sung P; Lee G; Arvin A
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563288
[TBL] [Abstract][Full Text] [Related]
4. STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways.
Kim JA; Park SK; Seo SW; Lee CH; Shin OS
J Invest Dermatol; 2017 Oct; 137(10):2101-2109. PubMed ID: 28647346
[TBL] [Abstract][Full Text] [Related]
5. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
Ogunjimi B; Theeten H; Hens N; Beutels P
J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
[TBL] [Abstract][Full Text] [Related]
6. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
[TBL] [Abstract][Full Text] [Related]
7. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
8. RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.
Jones M; Dry IR; Frampton D; Singh M; Kanda RK; Yee MB; Kellam P; Hollinshead M; Kinchington PR; O'Toole EA; Breuer J
PLoS Pathog; 2014 Jan; 10(1):e1003896. PubMed ID: 24497829
[TBL] [Abstract][Full Text] [Related]
9. Varicella-Zoster virus ORF9 is an antagonist of the DNA sensor cGAS.
Hertzog J; Zhou W; Fowler G; Rigby RE; Bridgeman A; Blest HT; Cursi C; Chauveau L; Davenne T; Warner BE; Kinchington PR; Kranzusch PJ; Rehwinkel J
EMBO J; 2022 Jul; 41(14):e109217. PubMed ID: 35670106
[TBL] [Abstract][Full Text] [Related]
10. Whole Transcriptome Analyses Reveal Differential mRNA and microRNA Expression Profiles in Primary Human Dermal Fibroblasts Infected with Clinical or Vaccine Strains of Varicella Zoster Virus.
Oh SJ; Lim S; Song MJ; Ahn JH; Lee CH; Shin OS
Pathogens; 2019 Oct; 8(4):. PubMed ID: 31658769
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Viral Replication by Cellular Replicative Senescence.
Kim JA; Seong RK; Shin OS
Immune Netw; 2016 Oct; 16(5):286-295. PubMed ID: 27799874
[TBL] [Abstract][Full Text] [Related]
12. Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus.
Jones JO; Arvin AM
Antiviral Res; 2005 Nov; 68(2):56-65. PubMed ID: 16118026
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular pathogenesis of varicella virus infection.
Gilden DH; Cohrs RJ; Mahalingam R
Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus infection of a human CD4-positive T-cell line.
Zerboni L; Sommer M; Ware CF; Arvin AM
Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
[TBL] [Abstract][Full Text] [Related]
15. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
[TBL] [Abstract][Full Text] [Related]
16. Varicella zoster virus immunity: A primer.
Duncan CJ; Hambleton S
J Infect; 2015 Jun; 71 Suppl 1():S47-53. PubMed ID: 25917799
[TBL] [Abstract][Full Text] [Related]
17. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
18. Key issues in varicella-zoster virus latency.
Kennedy PG
J Neurovirol; 2002 Dec; 8 Suppl 2():80-4. PubMed ID: 12491156
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
20. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.
Kennedy PG; Rovnak J; Badani H; Cohrs RJ
J Gen Virol; 2015 Jul; 96(Pt 7):1581-602. PubMed ID: 25794504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
